Consensus vs Tempus AI
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Consensus
Search engine for scientific research that tells you what the evidence...
Visit
|
|
|
|---|---|---|
| RECATOOLS Score | 7.3 / 10 | 8.2 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Freemium | Enterprise |
| Free tier | 20 searches per day with basic features | No free tier; enterprise contracts only |
| Paid from | $9.99/month (Premium) | Custom enterprise contracts; multi-year data-licensing subscriptions (price not publicly disclosed) |
| Has API | ✗ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✓ | ✗ |
| Users | 500k+ users | ~50% of US oncologists; 4,500+ hospital integrations; 40M+ clinical records |
| Founded | 2022 | 2015 |
| Maker | Eric Olson, Christian Salem | Tempus AI, Inc. (independent, Nasdaq: TEM) |
| Verdict | Consensus is an AI-powered academic search engine that answers questions by surfacing findings from peer-reviewed papers, complete with citations, a 'consensus meter' on yes/no questions and study-quality signals. For ev... |
Tempus AI is among the most data-rich precision oncology platforms in existence, with a self-reinforcing flywheel of clinical sequencing, molecular data, and real-world outcomes that no pure-software competitor can easil... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.